The Correlation Between Biological Markers and Prognosis in Thyroid Cancer

The Correlation Between Biological Markers and Prognosis in Thyroid Cancer

<b>Background:</b> Thyroid cancer incidence is rising globally. Papillary thyroid carcinoma (PTC) is the most common subtype, usually with a favorable prognosis, while follicular, medullary, and anaplastic thyroid carcinomas carry higher risks. This study examines the relationship betwee...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rami Hajjar, Ciprian Duta, Ionut Flaviu Faur, Catalin Prodan-Barbulescu, Hadi Alhajjar, Stelian Pantea
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Biomedicines
Subjects:	thyroid cancer <i>BRAF V600E</i> mutation papillary thyroid carcinoma thyroglobulin levels calcitonin levels biological biomarkers
Online Access:	https://www.mdpi.com/2227-9059/12/12/2826
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
by: Jennifer A. Silver, et al.
Published: (2021-11-01)

A combined model integrating deep learning, radiomics, and clinical ultrasound features for predicting BRAF V600E mutation in papillary thyroid carcinoma with Hashimoto’s thyroiditis
by: Peng-Fei Zhu, et al.
Published: (2025-08-01)

Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma
by: Muzi Li, et al.
Published: (2025-05-01)

Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
by: Bima Indra, et al.
Published: (2025-05-01)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
by: Woon Won Kim, et al.
Published: (2018-01-01)

Role of contrast-enhanced ultrasound with time-intensity curve analysis about thyroid nodule and parenchyma for differentiating BRAF V600E mutation status
by: Zhipeng Hu, et al.
Published: (2025-02-01)

THE ROLE OF BRAF V600E IN THE DEVELOPMENT OF THYROID CANCER PHENOTYPE: A SYSTEMATIC REVIEW
by: Pratia Mega, et al.
Published: (2025-01-01)

Relationship between the BRAF V600E and tumor size, lymph node, and distant metastasis in papillary thyroid carcinoma
by: Edmond Rukmana Wikanta, et al.
Published: (2022-06-01)

BRAF status in сito-morphological diagnosis of thyroid nodules
by: Yu. M. Tarashchenko, et al.
Published: (2020-08-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

Ultrasound features and thyroid function of patients with papillary thyroid carcinoma for predicting metastatic cervical lymph nodes with atypical ultrasound features
by: Shuting Li, et al.
Published: (2025-08-01)

Primary mucoepidermoid carcinoma of the thyroid with concomitant MAML2 gene rearrangement and BRAF V600E mutation – A case report
by: Frederica Loghides, et al.
Published: (2024-03-01)

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER
by: A. P. Polyakov, et al.
Published: (2017-04-01)

Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study
by: Hui Shi, et al.
Published: (2025-06-01)

SLPI as a dedifferentiation biomarker in BRAFV600E-mutant papillary thyroid cancer
by: Wei Luo, et al.
Published: (2025-08-01)

Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study
by: Suhaib Radi, et al.
Published: (2025-03-01)

Associations between pathological features and radioactive iodine-refractory recurrent papillary thyroid carcinoma: with mutation analysis using recurrent samples
by: Thi Nhung Nguyen, et al.
Published: (2025-05-01)

Prevalence of thyroid autoantibody positivity in women with infertility: a systematic review and meta-analysis
by: Yingqin Huang, et al.
Published: (2024-11-01)

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER
by: R. A. Murashko, et al.
Published: (2017-11-01)

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
by: N. V. Severskaya, et al.
Published: (2022-08-01)

Thyroglobulin-to-tumor volume ratio combined with ultrasound features for diagnosing thyroid follicular neoplasms
by: Xixi Zhu, et al.
Published: (2025-07-01)

Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report
by: Minoru Kihara, et al.
Published: (2022-03-01)

Diagnostic Value of Stimulated Serum Thyroglobulin in the Follow-up of Patients with Differentiated Thyroid Cancer
by: Vlado Wagenhofer, et al.
Published: (2024-01-01)

Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study
by: Hui Tang, et al.
Published: (2025-03-01)

Molecular mutations as a possible factor for determining extent of thyroid surgery
by: Joshua R. Krasner, et al.
Published: (2019-10-01)

Antithyroglobulin antibody as a marker of successful ablation therapy in differentiated thyroid cancer
by: Ayu Dewi, et al.
Published: (2017-01-01)

Current issues relating to diagnostics and treatment of papillary thyroid cancer with coexistent autoimmune thyroiditis
by: S. M. Zavhorodnyi, et al.
Published: (2020-10-01)

The correlation between thyroid status parameters and prolactin levels in reproductive-age women with autoimmune thyroiditis and subclinical hypothyroidism
by: Yu.V. Buldygina, et al.
Published: (2025-04-01)

Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
by: Budi Darmawan, et al.
Published: (2022-12-01)

Allele frequency in thyroid cancer: mechanisms, challenges, and applications in cancer therapy
by: Jiayu Huang, et al.
Published: (2025-05-01)

Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies
by: Daniele Ceruti, et al.
Published: (2025-08-01)

Thyroid differentiation profile for differentiated thyroid cancer
by: Anthony J McGoron, et al.
Published: (2025-02-01)

Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the <i>BRAF</i> p.V600E Mutation in a Subset of Cases
by: Feifan Chen, et al.
Published: (2024-06-01)

Papillary thyroid carcinoma with Hashimoto’s thyroiditis: impact and correlation
by: Shengpeng Yao, et al.
Published: (2025-04-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
by: Yoko Omi, et al.
Published: (2021-08-01)

Inter- and Intra-observer Reproducibility of Thyroid Fine Needle Aspiration Cytology: An investigation of Bethesda 2023 Using Immunohistochemical BRAFV600E Antibody
by: Erdogan Bahattin, et al.
Published: (2024-12-01)

Incidence of thyroid adverse events following immune checkpoint inhibitor treatment in patients with baseline positive thyroid antibodies: a systematic review and meta-analysis
by: Hui Yu, et al.
Published: (2025-07-01)

Thyroid Hemiagenesis: An Incidental Discovery during Treatment for Papillary Thyroid Carcinoma
by: Chang Haur Lee, et al.
Published: (2024-11-01)

The association between dietary sodium density and Hashimoto’s thyroiditis in US adults
by: Peilin An, et al.
Published: (2025-01-01)

Impact of Hashimoto’s thyroiditis on ultrasound diagnosis of papillary thyroid carcinoma: a retrospective study
by: Chao Teng, et al.
Published: (2025-05-01)